Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study

M. J. Pishvaian, G. J. Weiss, G. S. Falchook, N. Yee, M. Gil-Martin, S. Shahda, V. Moreno, I. Brana, M. Crittenden, S. Formenti, R. Al-Rajabi, K. P. Papadopoulos, E. Stankevich, M. Feng, J. Li, M. Mathias, G. Kroog, I. Lowy, M. G. Fury

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii410
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this